Nicotine Addiction – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
The widespread use of tobacco and related products contributes significantly to global health issues. The affordability of these items and the utilization of social media in marketing have played key roles in this trend. Nicotine addiction, mainly from smoking and chewing tobacco, is notorious for its quick development and challenging recovery process. Nicotine is a plant alkaloid primarily found in tobacco plants, with large leaf (Nicotiana tabacum) and small leaf (Nicotiana rustica) varieties serving as primary sources. It is commonly administered through smoking, chewing, and snorting fine powders, while it's also employed pharmacologically to aid in smoking cessation. Tobacco control measures have been a priority worldwide, with various nicotine substitutes such as patches, gums, e-cigarettes, and inhalation agents being promoted as effective solutions. The significant contributors to nicotine addiction encompass inadequate enforcement of smoking bans, limited education, especially in underdeveloped nations, a lack of motivation to quit smoking, insufficient training among mental health professionals, and subpar treatment options. Nicotine undergoes metabolism primarily in the liver, facilitated by the enzyme CYP2A6, which converts nicotine into cotinine. Cotinine is a marker for nicotine exposure, with wide variations in metabolism rates influenced by genetic polymorphisms in CYP2A6. Medications used for smoking cessation are as follows:
- Nicotine Replacement Products: These include items like skin patches and gum, though proper usage, such as the "bite and park" technique instead of chewing gum, is recommended.
- Nicotine Replacement Medications: Bupropion and, more recently, varenicline have demonstrated effectiveness in aiding smoking cessation, while Nortriptyline and Clonidine are considered second-line drugs.
- Reproductive effects of nicotine are predominantly fetal neuroteratogenic, and smoking has been linked to fetal growth retardation.
An estimated 50 million individuals in the United States are addicted to various tobacco products, including cigarettes, cigars, chewing tobacco, and snuff.
Thelansis’s “Nicotine Addiction Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Nicotine Addiction treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Nicotine Addiction across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Nicotine Addiction Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment